0001969223-24-000050.txt : 20240207 0001969223-24-000050.hdr.sgml : 20240207 20240207175948 ACCESSION NUMBER: 0001969223-24-000050 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 24606143 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 144 1 primary_doc.xml 144 0001585160 XXXXXXXX LIVE 0000872589 Regeneron Pharmaceuticals, Inc. 000-19034 777 Old Saw Mill River Road Tarrytown NY 10591 914-847-7000 Robert Landry Former CFO Common Stock UBS Financial Services Inc
1000 Harbor Blvd 3rd Floor Weehawken NJ 07086
2500 2375000 107943750 02/07/2024 NASDAQ
Common Stock 02/02/2024 Stock Option Exercise Company N 119 02/02/2024 Stock Common Stock 01/31/2024 Stock Option Exercise Company N 118 01/31/2024 Stock Common Stock 01/24/2024 Stock Option Exercise Company N 148 01/24/2024 Stock Common Stock 01/23/2024 Stock Option Exercise Company N 324 01/23/2024 Stock Common Stock 01/17/2024 Stock Option Exercise Company N 146 01/17/2024 Stock Common Stock 01/12/2024 Stock Option Exercise Company N 232 01/12/2024 Stock Common Stock 01/04/2024 Stock Option Exercise Company N 158 01/04/2024 Stock Common Stock 01/03/2024 Stock Option Exercise Company N 412 01/03/2024 Stock Common Stock 01/02/2024 Stock Option Exercise Company N 229 01/02/2024 Stock Common Stock 12/28/2023 Stock Option Exercise Company N 238 12/28/2023 Stock Common Stock 12/27/2023 Stock Option Exercise Company N 208 12/27/2023 Stock Common Stock 12/13/2023 Stock Option Exercise Company N 277 12/13/2023 Stock Common Stock 12/12/2023 Restricted Stock Award Company N 6119 12/12/2023 Stock Y 02/07/2024 /s/ UBS Financial Services Inc, as attorney-in-fact for Robert Landry